← Eichor
Study identifier: NCT07213609 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Condition: Neoplasms, Colorectal · Neoplasms  ·  Sponsor: GlaxoSmithKline

PhasePhase 1/Phase 2
Planned participants47
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Solid tumours are abnormal lumps of tissue that can occur in different parts of the body. The tumours involved in this study have specific genetic characteristics that can make them more aggressive and challenging to treat. The study will test whether GSK5460025 alone or in combination (potential combinations may be included in future amendments to the protocol) with other anti-cancer agents can decrease tumor size, is safe, well-tolerated, and how the drug is processed in the body over time.

This description comes directly from the study's public registry record.

Talk to the study team

US GSK Clinical Trials Call Center  ·  877-379-3718  ·  GSKClinicalSupportHD@gsk.com

EU GSK Clinical Trials Call Center  ·  +44 (0) 20 89904466  ·  GSKClinicalSupportHD@gsk.com

Always discuss trial participation with your own doctor first.

Locations (22)

GSK Investigational SiteAurora, Colorado, United StatesRecruiting
GSK Investigational SiteDetroit, Michigan, United StatesRecruiting
GSK Investigational SiteCanton, Ohio, United StatesRecruiting
GSK Investigational SiteNashville, Tennessee, United StatesRecruiting
GSK Investigational SiteHamilton, Ontario, CanadaRecruiting
GSK Investigational SiteToronto, Ontario, CanadaRecruiting
GSK Investigational SiteMontreal, Quebec, CanadaRecruiting
GSK Investigational SiteCopenhagen, DenmarkRecruiting
GSK Investigational SiteChiba, JapanRecruiting
GSK Investigational SiteOsaka, JapanRecruiting
GSK Investigational SiteTokyo, JapanRecruiting
GSK Investigational SiteTokyo, JapanRecruiting

+ 10 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07213609